Commercial Development of CGTs in Korea: Bringing Novel Technologies to Therapeutic Reality Presented by the ISCT Asia Regional Executive Committees Part 1 of the ISCT Asia Webinar Series Webinar Description: Exploring novel technologies...
March Webinar Recording_Edited.mp4
Webinar Description: The cancer vaccine webinar by ISCT is devoted to individuals associated with cancer vaccines, immune effective therapy programs, GMP cell processing laboratories, regulatory, quality and other forms of cancer immunotherapy. Key Learning Objectives: To...
Cancer Vaccines for Oncological Therapy.mp4
Webinar Description: In the second half of 6-part Cold Chain Webinar Series, we will cover common solutions to issues encountered in logistics and supply of getting ATMPs to intended destinations and patients. Part 4 revisits formulation and container selection by addressing how these...
Webinar Description: Hundreds of institutions now have access to commercial CAR T cells, but in parallel many institutions globally are looking to implement a more decentralized approach using partnerships or commercially available vectors and devices. Here we describe what is required to...
GMT20220915-150104_Recording_gallery_1920x1080.mp4
Webinar Description: This webinar will discuss the specific characteristics and biologic activity of a specialized population of cells derived from the vascular endothelium. These cells produce signaling molecules that stimulate the intrinsic progenitor cells that are resident is many...
GMT20220331-163021_Recording_gallery_2844x1200.mp4
Reprogramming hiPSC and differentiation: Challenges in getting stable lines and good differentiating candidates for cell therapies explained. Produced by: ISCT Asia Regional Executive Committee Sponsored by: ...
ISCT Asia Regional Webinar I Reprogramming hiPSC and differentiation-20210326 0030-1.mp4
Webinar Description: Two speakers provide a comparative discussion on challenges in development and manufacturing for NK cell therapies. Our first speaker, based in the US, discusses the topic through examples of manufacturing for solid and hematological malignancies. Our second speaker brings...
3 attachments
Join us as we hear from two Korean companies working to bring NK cell-based therapies to market. Both CAR-modified NK cells to treat malignant and recurrent blood cancers as well as combination therapy of NK cells and local immunogenic chemotherapy to treat hepatocellular carcinoma will be...
ISCT Webinar_Natural Killer (NK) Cell-based Strategies-06-28.mp4
Webinar Description: This webinar will review and share the most recent advances of cell & gene therapy and emerging technologies in malignant brain tumor treatment, the development of newer generation of chimeric antigen receptor-T cells for cancer treatment, as well as the clinical...
ISCT Asia Webinar Q4.mp4
Webinar Description: This webinar will present the underpinning mechanisms driving freeze thaw applications and their implications across varied drug product containment configurations and volumes. The links between controlled freezing rates, container design, and cellular outcomes are...
The Cryopreservation Process and its Impact On The Consistency of High-quality Cell Therapy Products.mp4
1 Comment - no search term matches found in comments.